Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131972) titled 'A Single Center, Single-Dose, Double-Blind, Randomized, Two-Period, Crossover Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-PEG, and US-Neulasta(R), and to Evaluate Safety in Healthy Adult Male Volunteers' on Sept. 8.
Study Type: Interventional study
Study Design:
Cross-over
Primary Sponsor: Hopeshine-Minsheng Hos pital of Xinzheng
Condition:
Neutropenia
Intervention:
Sequence 1:Cycle 1: NKF-PEG
Cycle 2: US-Neulasta
Sequence 2:Cycle 1: US-Neulasta
Recruitment Status: Recruiting
Phase: 1
Date of First Enrollment: 2026-07-21
Target Sample Size: Sequence 1:101;Sequenc...